BioSpace News Archive

Thermo Scientific Anionic Pesticides Explorer delivers high-throughput detection, identification and quantification of anionic polar pesticides in compliance with the latest EU regulations

Fresenius Medical Care North America’s Renal Therapies Group, the leading provider of kidney care products, today announced the launch of AquaBplus and AquaC UNO H water purification systems that will be available to all dialysis centers and hospitals in North America in the first quarter of 2020.

Entrada Therapeutics, a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics, today announced the appointment of Nathan J. Dowden as Chief Operating Officer.

Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products, announced today that it has purchased G&W Laboratories’ finished dosage manufacturing plant located in Lincolnton, NC.

Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (Foamix or the Company), a specialty pharmaceutical company, announced today the peer review publication of the long term open label safety portions of studies FX2014-04 and FX2014-05 (Studies 04 & 05) in the Journal of Clinical and Aesthetic Dermatology (JCAD).

Biocept, Inc. (NASDAQ: BIOC), announces that clinical data highlighting performance of the Company’s Target Selector™ tests and kits for detecting actionable oncology biomarkers will be presented at the 2019 Association for Molecular Pathology (AMP) Annual Meeting being held November 7-9,

PsychoGenics Inc., announced the appointment of Mark A. Varney, Ph.D., as Chief Scientific Officer (CSO). This appointment reflects the Company’s growth in Central Nervous System (CNS) drug discovery and clinical development, and its continued commitment to the development of proprietary technologies to support internal and partnered drug discovery and translational research.

Genprex, Inc., a clinical-stage gene therapy company, is publishing lung cancer prevention measures in an effort to educate the public, prevent new cases and raise awareness of lung cancer while supporting November’s Lung Cancer Awareness Month.

Immunomic Therapeutics, Inc., a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced that Immunomic scientists will present data from its oncology programs at the following scientific and medical conferences.

Apollo Endosurgery, Inc., a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced that Todd Newton, CEO, and Stefanie Cavanaugh, CFO, will host investor meetings at the 10th Annual Craig-Hallum Alpha Select Conference.